Candriam Equities L Biotech.C EUR Acc H/  LU1120766206  /

Fonds
NAV8/12/2020 Chg.+2.0800 Type of yield Investment Focus Investment company
182.2500EUR +1.15% reinvestment Equity Worldwide Candriam Luxembourg 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2015 - 4.50 1.83 -5.03 10.78 0.59 4.26 -10.61 -11.54 7.84 3.34 0.40 +4.26%
2016 -23.30 -4.50 3.68 3.70 5.38 -8.64 12.35 -2.51 3.83 -12.88 9.14 -3.00 -20.47%
2017 5.33 6.69 -0.05 0.89 -3.15 9.22 2.21 6.71 0.69 -6.82 -0.16 1.27 +24.05%
2018 6.44 -4.86 -2.41 -3.43 4.27 0.55 4.17 3.82 -2.27 -14.27 3.77 -8.62 -14.03%
2019 12.76 3.32 -0.89 -5.21 -4.74 9.15 -2.47 -2.55 -4.76 10.91 11.78 2.49 +30.88%
2020 -5.47 -1.64 -5.49 12.16 9.41 1.19 -3.05 -0.76 - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 35.73% 38.88% 29.84% 24.14% 25.56%
Sharpe ratio 0.24 0.19 0.87 0.30 0.08
Best month +12.16% +12.16% +12.16% +12.76% +12.76%
Worst month -5.49% -5.49% -5.49% -14.27% -23.30%
Maximum loss -25.42% -25.42% -25.54% -26.62% -36.32%
Outperformance -5.24% - +1.44% -12.51% -9.80%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
Candriam Equities L Biotech.V US... reinvestment 1,727.9399 +29.22% +35.30%
Candriam Equities L Biotech.I EU... reinvestment 1,882.9700 +26.35% +25.07%
Candriam Equities L Biotech.R US... reinvestment 220.9500 +29.36% +35.73%
Candriam Equities L Biotech.R EU... reinvestment 184.3700 +26.37% -
Candriam Equities L Biotech.I US... reinvestment 4,751.7300 +29.19% +34.98%
Candriam Equities L Biotech.C EU... reinvestment 182.2500 +25.44% +21.91%
Candriam Equities L Biotech.C US... reinvestment 717.3800 +28.35% +32.61%
Candriam Equities L Biotech.C US... paying dividend 671.6700 +28.31% +32.49%

Performance

YTD  
+4.99%
6 Months  
+3.40%
1 Year  
+25.44%
3 Years  
+21.91%
5 Years  
+7.36%
Since start  
+21.50%
Year
2019  
+30.88%
2018
  -14.03%
2017  
+24.05%
2016
  -20.47%
2015  
+4.26%